Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of RAS Inhibitors on Perioperative Myocardial Injury in Colorectal Cancer Surgery
NCT06862115Phase 3Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Mar 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of myocardial injury at 48 hours. Started Mar 2025; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06862115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06862115.